ExpreS2ion Biotech Holding AB (publ) (STO: EXPRS2)
Sweden
· Delayed Price · Currency is SEK 20.80
-1.20 (-5.45%)
Dec 27, 2024, 5:29 PM CET
STO: EXPRS2 Revenue
ExpreS2ion Biotech Holding AB had revenue of 1.69M SEK in the quarter ending September 30, 2024, a decrease of -9.00%. This brings the company's revenue in the last twelve months to 7.93M, down -2.06% year-over-year. In the year 2023, ExpreS2ion Biotech Holding AB had annual revenue of 8.80M with 43.07% growth.
Revenue (ttm)
7.93M
Revenue Growth
-2.06%
P/S Ratio
3.79
Revenue / Employee
440.61K
Employees
21
Market Cap
43.27M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 25.44B |
| Sectra AB | 3.14B |
| Getinge AB | 33.59B |
| Camurus AB | 1.69B |
| Vitrolife AB | 3.56B |
| Bonesupport Holding AB | 814.46M |
| Elekta AB | 17.72B |
| Vimian Group AB | 3.99B |